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T lymphoid-primed progenitors are hematopoietic
progenitors destined to enter the thymus. The
in vivo characterization of these embryonic pro-
genitors is challenging, however, due to the intra-
uterine development of mouse embryos. Thus,
how the fate of these cells is determined has not
been fully defined in mammals. Here we use
zebrafish embryos to show that the homing of
T lymphoid-primed progenitors to the thymus is
impaired, concomitant with a decrease in ccr9a
expression, in the absence of irf4a. Strikingly, fate
mapping assays at the single-cell level showed
a fate change of irf4a-deficient T lymphoid-primed
progenitors to myeloid cells, accompanied by an
increase in Pu.1 expression. These data indicate
that in addition to regulating ccr9a expression,
Irf4a is essential in T lymphoid-primed progenitors
for repressing Pu.1 expression to prevent an alter-
nate fate. Our findings provide insight into the fate
determination mechanism of T lymphoid-primed
progenitors.
INTRODUCTION
In vertebrates, all blood cells are generated through hematopoi-
esis. In the embryo, hematopoiesis occurs at least twice, in prim-
itive and definitive waves. Hematopoietic stem cells (HSCs) are
generated during the definitive wave and give rise to various
blood lineages, including lymphoid cells, myeloid cells, and
erythroid cells. At least two models have been proposed for
lymphocyte development from HSCs. In the classical model, T
and B cells are generated directly from common lymphoid pro-
genitor (CLP) cells, which have restricted lymphoid potential
(Kondo et al., 1997), whereas in the alternative model, a
lymphoid-primed multipotent progenitor (LMPP) is proposed
that is endowed with both lymphoid and myeloid potentials
(Adolfsson et al., 2005). Although the origins of lymphocytes
are still contentious in these models, it is unanimous that the
migration of lymphoid progenitor cells to the thymus is required
for T cell development.DevelopmenT cell development in the thymus has been extensively
studied, and many extrinsic and intrinsic factors were reported
to be involved in this process (Shah and Zu´n˜iga-Pflu¨cker,
2014). For example, Notch signaling is found to be essential
for the fate commitment of early T cell progenitor (ETP)
cells (Sambandam et al., 2005; Tan et al., 2005). In addition,
several transcription factors are indispensible for T cell
specification, differentiation, and survival, such as Bcl11b (Li
et al., 2010), TCF1 (Weber et al., 2011), and GATA3 (Garcı´a-
Ojeda et al., 2013). However, at the prethymic stage, the crit-
ical factors for the fate determination of T lymphoid-primed
progenitors are not fully explored and the underlying mecha-
nisms of T lymphoid-primed progenitor commitment remain
elusive (Rodewald, 1995; Rodewald et al., 1994; Yang et al.,
2010).
Interferon regulatory factor 4 (IRF4) is a member of the inter-
feron regulator factor family that is implicated in the immune
system (Tamura et al., 2008). The functions of transcription factor
IRF4 have been extensively studied in the development of T and
B cell subsets, including regulatory T cells (Cretney et al., 2011;
Vasanthakumar et al., 2015), CD4+ helper T cell subsets (Gao
et al., 2013; Staudt et al., 2010), CD8+ T cells (Raczkowski
et al., 2013; Yao et al., 2013), and plasma cells (Klein et al.,
2006; Ochiai et al., 2013). But the role of IRF4 in early T cell devel-
opment at prethymic stages during embryogenesis remains
undefined.
Zebrafish is a valuable model for studies on T cell and
thymic development (Langenau and Zon, 2005; Ma et al.,
2012; Trede et al., 2004). In this study, the expression
of irf4a (previously named irf4) was examined first in early ze-
brafish embryos and observed in hematopoietic regions, in-
cluding the caudal hematopoietic tissue (CHT) and thymus,
indicating that it may function in T cell development at embry-
onic stages. As anticipated, loss of function assays by deletion
or knockdown of irf4a resulted in T cell deficiency in the
thymus. At the prethymic stage, loss of ccr9a (previously
named ccr9) expression was also observed in Irf4a-deficient
embryos, accounting for the impairment of T cell progenitor
homing to the thymus. Interestingly, in the absence of Irf4a,
these progenitors not only lost homing ability but also adopted
a myeloid cell fate by upregulation of pu.1, indicating that Irf4a
is required for T lymphoid-primed progenitor fate by repres-
sing pu.1 expression to avoid the myeloid cell fate, in addition
to promoting T lymphoid-primed progenitors trafficking to the
thymus.tal Cell 34, 621–631, September 28, 2015 ª2015 Elsevier Inc. 621
Figure 1. Irf4 Is Expressed in Lymphoid Progenitors at Embryonic Stages
(A) Expression pattern of irf4a examined by WISH. The expression of irf4a was observed in the CHT at 2 dpf and later in the thymus at 3 dpf. Red arrows indicate
irf4a-expressing cells. The magnified view of the boxed region is shown in the right panel, and the thymus is denoted with red circle.
(B) Absence of irf4a expression in the CHT of the cloche mutants and runx1 morphants.
(C) qPCR of irf4a in sorted cells from 3-dpf transgenic embryos. Irf4a is highly expressed in cmyb:EGFP+ cells relative to negative cells but is not expressed in
mpo:EGFP cells or gata1:GFP cells. The purity ofmpo:EGFP cells or gata1:GFP cells was validated by the high expression level of lyz or gata1, respectively, with
b-actin as the control. ***p < 0.001. nd, not detectable.
(D) Expression of irf4a in a subset of cmyb-expressing cells in the CHT revealed by double color FISH. The cell denoted by the white arrow is shown in the insets
with a magnified view. Scale bar, 20 mm.
(E) Western blot showed the protein level of IRF4 in the FL (E11.5, E12.5, and E14.5) or thymus (E16.5) of mouse embryos.
(F) Expression of IRF4 in the FL of E14.5 mouse embryos examined by immunochemistry. Red arrows indicate IRF4-expressing cells. Scale bar, 200 mm.
(G) qPCR analysis of the relative mRNA level of Irf4 in purified hematopoietic cells from the FL of E13.5 mouse embryos.
(H) Expression of IRF4 was observed in CCR9+ cells sorted and photographed using FlowSight (Merck-Millipore). Scale bar, 20 mm. All data are mean ± SD.
See also Figure S1 and Table S1.RESULTS
Irf4a Is Expressed in Lymphoid Progenitor Cells at
Embryonic Stages
To investigate the function of Irf4 in embryonic stages, we first
examined the expression pattern of irf4 in zebrafish embryos
by whole-mount in situ hybridization (WISH). Our results showed
that although the expression of irf4b was not observed in he-622 Developmental Cell 34, 621–631, September 28, 2015 ª2015 Elsmatopoietic regions (data not shown), the expression of irf4a
(NCBI gene ID 100002070) was mainly detected in the CHT
at 2 days post-fertilization (dpf) and in the thymus region at
3–4 dpf (Figures 1A and S1A). In contrast, irf4a expression was
not observed in the caudal region of cloche mutants, which are
defective in hematopoiesis (Stainier et al., 1995), or of runx1mor-
phants (Gering and Patient, 2005; Kissa and Herbomel, 2010),
which lack definitive HSCs (Figure 1B), indicating that irf4a isevier Inc.
indeed expressed in hematopoietic cells derived from HSCs. To
find out which type of blood lineage cells expressed irf4a, we
examined its relative mRNA level with qPCR in three types of
hematopoietic cells. Our data showed that irf4a was highly ex-
pressed in cmyb:EGFP+ cells (hematopoietic stem and progen-
itor cells, HSPCs) at 3 dpf, but no irf4a expression was detected
inmpo:EGFP+ (granulocytic) and gata1:GFP+ erythroid cells (Fig-
ure 1C). Double fluorescence in situ hybridization (FISH) further
revealed that irf4a was co-expressed with cmyb (Figure 1D)
but not with mpo (a neutrophil marker) or mfap4 (a macrophage
marker) in the CHT region of 2-dpf zebrafish embryos (Figures
S1B and S1C). Therefore, the expression of irf4a was observed
in a subset of cmyb-expressing HSPCs but not in differentiated
myeloid and erythroid cells, implying that irf4a may be specif-
ically expressed in hematopoietic progenitor cells with lymphoid
potential at embryonic stages.
To further demonstrate the expression of Irf4 (the homolog to
irf4a in zebrafish) in mouse embryos, we first examined the level
of IRF4 protein in mouse fetal liver (FL) and thymus by western
blotting. The results showed that IRF4 protein was present in
the FL at embryonic day (E) 11.5–14.5 and in the thymus at
E16.5 (Figure 1E). The expression of IRF4 protein in the FL at
E14.5 was confirmed by immunochemistry analyses (Figure 1F).
To determine the cell types in the FL that express Irf4, we
examined the mRNA level of Irf4 in various purified hemato-
poietic cells, including CCR9+ progenitors with T cell-primed
fate (Schwarz et al., 2007). qPCR analysis showed that Irf4
expression was much higher in lymphoid-restricted progenitors,
especially in CCR9+ T cell progenitors, compared to its expres-
sion in HSC and LMPP (Figure 1G). Moreover, the expression
of IRF4 protein was observed in T cell progenitors with CCR9
expression sorted from the FL (Figure 1H). Taken together, these
data suggest that at embryonic stages, Irf4 is expressed in
lymphoid-primed progenitors in mammals as it in zebrafish.
Homing of Lymphoid Progenitors to the Thymus Is
Impaired in the Absence of Irf4a
To investigate whether Irf4a is essential for lymphoid cell devel-
opment during zebrafish embryogenesis, knockdown experi-
ments were conducted by injection of anti-sense morpholinos
(MO) into zebrafish embryos at the one-cell stage. The protein
level of Irf4a was evaluated using western blotting to verify the
effectiveness of the irf4a translation-blocking MOatg. The result
showed that compared with the control, Irf4a expression was
markedly decreased following irf4aMOatg injection (Figure S2A).
Moreover, WISH showed the lack of rag1 expression in irf4a
MOatg-injected embryos (Figure S2B). An irf4a splice-blocking
MO was also used, and its specificity was validated with RT-
PCR (Figures S2C and S2D). It was found that the expression
of rag1 was absent in embryos injected with splice MO but
was normal in embryos injected with a mismatch MO of irf4a
(Figure S2E), indicating that loss of rag1 expression was specif-
ically caused by knockdown of irf4a. To validate this observation,
we generated an irf4a null mutant with a 7-bp deletion in the first
exon (41 bp after the start codon 50-ATG-30) by using TAL
effector nucleases (TALEN) (Figures 2A and 2B). Endogenous
expression of irf4a was not detected in this mutant (Figures
S2F and S2G). Then we examined the expression of T cell
markers in the mutant using WISH and found that the expressionDevelopmenof rag1, lck, and tcrawas almost absent in themutant (Figure 2C),
indicating that T cell development was disturbed in the absence
of Irf4a. To obtain cellular evidence of the previously mentioned
defects, we examined the thymic cell populations of control and
irf4amorphant embryos using transmission electron microscopy
(TEM). We found that the thymus of control embryos at 4 dpf was
filled with thymic epithelial cells (TECs) and dark-staining T lym-
phocytes, while only TECs were observed in the thymus of irf4a
morphants (Figure 2D). Furthermore, when irf4a was knocked
down in cmyb:EGFP transgenic fish, the number of GFP+ cells
in the thymus was greatly reduced at 4 dpf (Figures 2E and
2F), indicating that T lymphocytes were deficient in irf4a mor-
phants. Taken together, these data indicate that irf4a is indis-
pensable for early T cell development in zebrafish embryos.
The generation of T cells comprises a series of steps, including
the specification from HSCs, migration to the thymus, commit-
ment to ETPs, and subsequent survival, proliferation, and differ-
entiation. The absence of T cell progenitors in irf4a-deficient
embryos might be caused by defects in any of these steps. First,
at 36 hours post-fertilization (hpf), the HSC markers runx1/cmyb
were expressed normally in embryos with irf4a knockdown (Fig-
ure S3), indicating that T cell deficiency in irf4a morphants does
not stem from a HSC defect. However, the expression of cmyb,
ikaros, and coro1a in the thymus was absent in irf4a morphants
at 3 dpf (Figure 2G). In addition, the reduction of coro1a GFP+
cells (which can mark both myeloid and lymphoid lineages in ze-
brafish) (Li et al., 2012a) in the thymus of irf4a morphants was
not accounted for by apoptosis, as confirmed by TUNEL assay
(Figure 2H). Subsequently, we tried to determine whether the
impaired expression of these markers in the thymus arose from
a blockade of the homing process of T cell progenitors. Time-
lapse imaging of the homing process from 2.5 to 3.5 dpf was
performed to investigate the functional consequences of irf4a
knockdown on the trafficking of T cell progenitors to the thymus
in vivo. To exclude the possibility of myeloid cells also marked by
coro1a expression, coro1a:EGFP/lyz:DsRed double transgenic
embryos (lyz:DsRed expression marks neutrophils specifically)
were used. The GFP+ cells with a round shape different from
macrophage were seen to migrate to the thymus rudiment in
control embryos, but few of this type of cell were observed in
the thymus of irf4amorphants (Movie S1 and Figure 3A). Further
quantitative analysis showed that the number of coro1a:EGFP
cells entering the thymus every 30 min was significantly reduced
in Irf4a-deficient embryos, and as a result, nearly none of these
embryos had comparable number of coro1a:EGFP cells in the
thymus relative to the control (Figures 3B and 3C). Together,
these data indicate that the homing process of T cell progenitors
is impaired as a consequence of irf4a knockdown.
The Reduction of ccr9a Expression Leads to a Homing
Defect
Chemokines are thought to be important for attracting lymphoid
progenitors to the thymus (Bleul and Boehm, 2000; Hess and
Boehm, 2012).The expression of ccl25, an indispensable che-
mokine for the homing process, is regulated by Foxn1, which
is important for the maintenance of TECs during T cell develop-
ment in zebrafish (Ma et al., 2012). WISH showed that at 3 dpf,
the expression of foxn1 and ccl25 (including ccl25a and ccl25b
in zebrafish) was unaltered in irf4a morphants (Figures 3D andtal Cell 34, 621–631, September 28, 2015 ª2015 Elsevier Inc. 623
Figure 2. T Cell Development Is Impaired in irf4a-Deficient Embryos
(A) Location and sequence of the TALEN target site for the irf4a gene.
(B) Sequence flanking the TALEN target site in F2 embryos. The deletion of seven nucleotides is shown in the black box.
(C) Expression of rag1, lck, and tcra in the thymus (red arrow) of the siblings and irf4amutants at 4 or 5 dpf. The embryos forWISHwere obtained from an incross of
genotyped heterozygous irf4a mutants.
(D) Cellular structure of the thymus in the control and irf4a morphants at 4 dpf. The transverse sections were observed with TEM. L, lymphocyte; E, thymic
epithelial cells. Scale bar, 2 mm.
(E) Confocal images of cmyb:EGFP cells in the thymus of the control or irf4amorphants at 4 dpf. Thewhite circle indicates the thymus region below the otic vesicle
(OV), denoted with the white dashed line. Scale bar, 20 mm.
(F) Enumeration of cmyb:EGFP cells in the thymus of the control and irf4a morphants at 4 dpf. ***p < 0.001.
(G) Expression of cmyb, ikaros, and coro1a in the thymus (red arrow) of the control and irf4a morphants at 3 dpf.
(H) TUNEL assay of the control and irf4amorphants at 3 dpf. The irf4aMOatg was injected into coro1a:EGFP transgenic embryos. The white circle indicates the
thymus region behind the eye (E), denoted with the white dashed line. White arrows denote apoptotic cells. Scale bar, 40 mm. All data are mean ± SD.
See also Figure S2.3E). These data indicate that the impairment of the homing pro-
cess is not attributable to dysregulated chemokine production
in the case of irf4a knockdown. Chemokine receptors are also
involved in regulating the homing of T lymphoid-primed pro-
genitors to the thymus in mouse (Caldero´n and Boehm, 2011;
Liu et al., 2006). In zebrafish, among chemokine receptors ex-624 Developmental Cell 34, 621–631, September 28, 2015 ª2015 Elspressed in the thymus (Bajoghli et al., 2009; Ma et al., 2012),
only ccr9a was found to be first expressed in the CHT at 2 dpf,
confirming the presence of thymus-fated cells in the CHT at pre-
thymic stages. This prompted us to examine the expression of
ccr9a in irf4amorphants. A significant downregulation of expres-
sion of the receptor ccr9a in the thymus and CHT region wasevier Inc.
Figure 3. Homing Process Is Disturbed due
to the Reduced Expression of ccr9a
(A) Confocal imaging of coro1a:EGFP/lyz:DsRed
embryos showing no coro1a:EGFP cells in the
thymus (white circle) in irf4amorphants. Scale bar,
40 mm.
(B) Number of coro1a:EGFP cells entering the
thymus every 30 min in the control and irf4a
morphants (n = 6) during the homing process. *p <
0.05.
(C) Quantification of embryos with coro1a:EGFP
cells (>5) in the thymus of the control (n = 88) and
irf4a morphants (n = 92) at 3.5 dpf.
(D) Expression of foxn1 in the control and irf4a
morphants at 3 dpf.
(E) Expression of ccl25a and ccl25b in the control
and irf4a morphants at 3 dpf.
(F) Expression of ccr9a in the control and irf4a
morphants at 3 dpf. Red arrows indicate the
thymus or perithymic region.
(G) Expression of cmyb, ikaros, and ccr9a in the
CHT of the control and irf4a morphants at 2 dpf.
Red arrows indicate hematopoietic progenitors
expressing cmyb, ikaros, or ccr9a in the CHT
region.
(H) qPCR analysis of cmyb, ikaros, and ccr9a in the
control and irf4a morphants at 2 dpf. ns, not sig-
nificant. **p < 0.01. All data are mean ± SD.
See also Figure S3 and Movie S1.observed (Figures 3F and 3G), although the expression of he-
matopoietic progenitor markers, cmyb and ikaros, was not
altered in irf4a morphants (Figures 3G and 3H).
The Expression of ccr9a Is Regulated by Irf4a
Several possibilities could explain the reduction of T cell progen-
itors expressing ccr9a, including increased apoptosis, reduced
proliferation of these progenitors, or downregulation of ccr9a
expression. Compared to control embryos, the number of
apoptotic cells in the CHT region was not increased in irf4amor-
phants, as indicated by TUNEL assay (Figure S4A). Next, we per-
formed a bromodeoxyuridine (BrdU) incorporation assay and
found that cell proliferation was comparable between control
embryos and irf4a morphants (Figure S4B). Subsequently, we
tried to determine whether Irf4a is required to induce the expres-
sion of ccr9a. The co-expression of irf4a and ccr9a in the CHT of
2-dpf embryos was confirmed by double FISH (Figure 4A). In
addition, the relative mRNA expression of both irf4a and ccr9aDevelopmental Cell 34, 621–631, Sewas found to be much higher in GFP+
cells than in GFP cells sorted from 2-
dpf coro1a:EGFP transgenic embryos
(Figure 4B). The co-expression of ccr9a
and irf4a and downregulation of ccr9a
but maintenance of ikaros upon irf4a
knockdown suggest that the expression
of ccr9a may be regulated by Irf4a.
Bioinformatics revealed the presence
of Irf4 binding sites, as reported by recent
studies in mammals (Li et al., 2012b;
Ochiai et al., 2013), 0.5 kb upstream of
the transcription start site of ccr9a (Fig-ure 4C). To determine whether Irf4a can bind this region directly,
we injected embryos at the one-cell stage with myc-tagged
Irf4a encoding mRNA and conducted chromatin immunoprecip-
itation (ChIP) experiments at 2 dpf. We found that an enrichment
of a DNA fragment containing these binding sites was immuno-
precipitated by anti-Myc antibody (Figures 4D–4F). To further
determine whether ccr9a expression is regulated by Irf4a, we
performed a luciferase reporter assay in HEK293 cells, and the
result showed that the expression of a full-length Irf4a coding
sequence (CDS) significantly upregulated the activity of the
ccr9a promoter. This effect was reduced when the Irf4 binding
sites were mutated (Figure 4G). These results suggest that
Irf4a can directly bind the promoter of ccr9a to regulate its
expression.
To determine whether ccr9a is required for T lymphoid devel-
opment, we performed ccr9a knockdown experiments. WISH
showed that the expression of rag1 in the thymus was also
decreased in ccr9a morphants (Figure 4H), which mimics theptember 28, 2015 ª2015 Elsevier Inc. 625
Figure 4. ccr9a Is a Direct Target of Irf4a
(A) Co-expression of irf4a and ccr9a in the CHT of
2-dpf embryos revealed by double color FISH.
Scale bar, 100 mm.
(B) qPCR of irf4a and ccr9a in GFP+ cells relative to
negative cells sorted from coro1a:EGFP trans-
genic embryos at 2 dpf. *p < 0.05; **p < 0.01.
(C) Schematic diagram of the ChIP and reporter
assay. The ccr9a-CF and CR are the control for-
ward and reverse primers, which are used to
amplify the ccr9a promoter region without the
conserved Irf4 binding site. The ccr9a-1F and 1R
represent primers used to amplify the promoter
region with two conserved Irf4 binding sites within
500 bp upstream of 50-ATG-30. AICE, AP-1-IRF
composite elements; EICE, Ets-IRF composite
elements.
(D) Myc was detected in embryos injected with
irf4a-myc mRNA by western blot.
(E) Direct binding of ccr9a promoter by Irf4a
examined by ChIP assay.
(F) qPCR of DNA fragments obtained from ChIP
assay with primers (ccr9a-1F, 1R or CF, CR). ***p <
0.001.
(G) Reporter assay showed the regulation of ccr9a
promoter by Irf4a full-length CDS. M1 indicates
that 50-TGAT-30 within AICE was mutated to 50-
GTCG-30, and M2 indicates that 50-GGAA-30
within EICEwasmutated to 50-TTCC-30. **p < 0.01;
*p < 0.05.
(H) Expression of rag1 in the thymus (red arrow) of
the control and ccr9a morphants at 4 dpf. All data
are mean ± SD.
See also Figure S4 and Table S2.phenotype of irf4a morphants. Taken together, these data sug-
gest that Irf4a regulates the expression of ccr9a, which in turn
controls the homing of T cell progenitors to the thymus.
Irf4a-Deficient T Lymphoid-Primed Progenitors Adopt
Myeloid Cell Fate
As the development of T lymphoid lineage was impaired upon
irf4a knockdown, what happened to erythroid or myeloid lineage
in this case? To address this question, the markers of erythroid
cells were examined by WISH first, and the result showed that
the expression of gata1 and be1-globin was unaltered in irf4a-
deficient embryos (Figure S5A). Then we further examined in
irf4a mutants the expression of coro1a, which marks leukocytes
including lymphoid cells and myeloid cells. WISH showed that in
the irf4a mutant, the expression of coro1a was absent in the
thymus but increased strikingly in the CHT region (Figure 5A).
A similar phenotype was observed in irf4a morphants (Fig-
ure S5B). To confirm this phenotype, we knocked down irf4a in
coro1a:EGFP transgenic embryos. As expected, the GFP+ cells
were nearly absent in the thymus but markedly increased in the
CHT region (Figure 5B). We further evaluated the total numbers
of coro1a:EGFP+ cells in the whole embryos by fluorescence-
activated cell sorting (FACS). The total number of GFP+ cells626 Developmental Cell 34, 621–631, September 28, 2015 ª2015 Elswas comparable between irf4a morphants and control embryos
(Figures 5C and 5D). In addition, the relative mRNA level of
coro1a in the whole body of irf4a morphants was not changed
relative to control embryos (Figure S5C).These results support
the notion that the expansion of the myeloid cell population
may originate from T cell progenitors that lost homing ability.
To determine which type of coro1a:EGFP+ cell population was
increased in irf4amorphants, we further examined the expression
of mfap4 (a macrophage marker) and lyz (a neutrophil marker) in
the CHT. WISH showed that the expression of both mfap4 and
lyz was increased (Figure 5E), indicating that an expansion of
the myeloid cell population occurs upon irf4a knockdown.
To directly observe the fate change of irf4a-expressing cells to
myeloid cells in vivo, fate mapping experiments at single-cell
resolution were performed. An irf4a:GFP transgenic line was
generated to mark and trace Irf4a-expressing cells (Figure S5D).
In irf4a:GFP/lyz:DsRed double transgenic embryos, the fate
change of GFP+ cells to DsRed+ myeloid cells was not detect-
able in wild-type embryos but was evident in embryos upon
irf4a knockdown (Figure S5E). To confirm this data, a stable
lyz:DsRed transgenic line with an Irf4a-GFP knockin (to block
endogenous Irf4a expression, i.e., loss of function of irf4a)
was constructed using the TALEN method to directly visualizeevier Inc.
Figure 5. Irf4a-Deficient Lymphoid Progenitors Turn to Myeloid Cells
(A) Expression of coro1a in the siblings and irf4amutants at 3 dpf. The black arrowhead indicates the thymus, and the red arrow indicates the coro1a-expressing
cell in the CHT.
(B) Confocal images of coro1a:EGFP cells in the thymus (white circle) and CHT of the control and irf4a morphants at 3 dpf. Scale bar, 80 mm.
(C) Representative FACS analysis of whole-body coro1a:EGFP cells in the control and irf4a morphants at 3 dpf.
(D) Enumeration of whole-body coro1a:EGFP cells shown in (C). Data are representative of three independent experiments (n = 180). ns, not significant.
(E) Expression of mfap4 and lyz in the CHT of the control and irf4a morphants at 3 dpf. Red arrows indicate myeloid cells expressing mfap4 or lyz.
(F) Brief diagram of irf4a knockin construct and generation of transgenic line for single-cell tracing.
(G) Time-lapse imaging of the conversion of the irf4a-deficient cell with EGFP knockin to express lyz:DsRed in the CHT from 58 to 66 hpf. Scale bar, 10 mm.
(H) Confocal images of cmyb:EGFP/lyz:DsRed embryos showing cmyb:EGFP, lyz:DsRed, or yellow cells in the CHT of the control or irf4a morphants at 3 dpf.
Scale bar, 40 mm.
(I) Enumeration of cmyb:EGFP, lyz:DsRed, or yellow cells shown in (H). **p < 0.01; *p < 0.05. All data are mean ± SD.
See also Figure S5 and Movie S2.irf4a-GFP+ cells in the absence of endogenous Irf4a expression.
As expected, in these embryos several irf4a+lyz+ (yellow) cells,
different from single lyz-DsRed cells, were observed in the
CHT at 3 dpf, implying that these irf4a+lyz+ cells might originate
from irf4a-expressing lymphoid-primed progenitors with GFP
knockin (Figure 5F). Interestingly, time-lapse confocal imaging
further showed that the GFP+ cells gradually turned yellow due
to the expression of DsRed driven by the lyz promoter (myeloid
cells) in these transgenic embryos from 58 to 66 hpf (Figure 5G;
Movie S2), indicating that these progenitors turn to myeloid cells
when Irf4a is deficient. In addition, when irf4a MO was injectedDevelopmeninto cmyb:EGFP/lyz:DsRed double transgenic embryos, we
found that GFP+-only cells were rarely observed at 3 dpf,
whereas the number of cmyb+lyz+ double positive yellow cells
was significantly increased in the CHT region; this implies that
Irf4a-deficient cmyb+ GFP+ cells that were initially lymphoid pro-
genitors adopted the myeloid cell fate as marked by lyz:DsRed
expression (Figures 5H and 5I). This finding provides additional
evidence to support the hypothesis of a cell fate change.
Taken together, we conclude that in addition to its role in regu-
lating T cell trafficking, Irf4amight prevent T cell progenitors from
adopting an alternate cell fate.tal Cell 34, 621–631, September 28, 2015 ª2015 Elsevier Inc. 627
Figure 6. Expression of pu.1 Is Negatively
Regulated by Irf4a
(A) Expression of pu.1 in the CHT of the siblings
and irf4amutants at 3 dpf examined byWISH. Red
arrows indicate pu.1-expressing cells.
(B) qPCR of pu.1 and other myeloid genes
including csf1r, csf3r,mfap4, and lyz in the control
and irf4a morphants at 3 dpf. **p < 0.01; ***p <
0.001.
(C) Protein level of Irf4 and Pu.1 in the control and
irf4a morphants at 3 dpf assayed by western blot.
(D) Schematic diagram of the pu.1 promoter with
the Irf4 binding site. The pu.1-CF and CR are the
control forward and reverse primers, which are
used to amplify the pu.1 promoter region without
the conserved Irf4 binding site. The pu.1-1F and
1R represent primers used to amplify the promoter
region with the conserved Irf4 binding site within
2,000 bp upstream of 50-ATG-30.
(E) Direct binding of the pu.1 promoter by Irf4a
examined by ChIP assay.
(F) qPCR of DNA fragments obtained from ChIP
assay with primers (pu.1-1F, 1R or CF, CR). ***p <
0.001.
(G) ChIP assay showing the acetylation level
(H3K27Ac and H3K9Ac) of the pu.1 promoter re-
gion (pu.1-1F, 1R) in the control or irf4amorphants
at 3 dpf. **p < 0.01; *p < 0.05.
(H) ChIP assay showing the enrichment level of
DNA fragments (pu.1-1F, 1R) by Hdac1 in the
control or irf4a morphants at 3 dpf. **p < 0.01. All
data are mean ± SD.
See also Figure S6 and Table S2.The Increased Population of Myeloid Cells Is Induced by
Upregulation of Pu.1
It is well known that the Ets transcription factor PU.1/Spi-1 is a
master regulator during the earliest step of myeloid cell develop-
ment in mice (Nerlov and Graf, 1998). Similarly, suppression of
Pu.1 by injection of pu.1 MO into zebrafish embryos blocks the
development of both macrophages and neutrophils (Bukrinsky
et al., 2009). To figure out whether Pu.1 is involved in the expan-
sion of the myeloid cell population in irf4a-deficient embryos, the
expression of pu.1 was examined by WISH. Our results showed
increased pu.1 expression in the irf4a mutant (Figure 6A). qPCR
experiments confirmed the increase of the mRNA level of pu.1
and other myeloid genes including csf1r, csf3r, mfap4, and lyz
in irf4a morphants (Figure 6B). Western blotting further sup-
ported increased Pu.1 expression at the protein level, concomi-
tant with the decreased Irf4a protein expression in irf4a mor-
phants (Figure 6C). To validate whether the expansion of the
myeloid cell population is Pu.1 dependent, we knocked down
irf4a and pu.1 simultaneously with MO co-injection. We found
that the increase of myeloid cell population in irf4a morphants
was blocked by pu.1 knockdown (Figure S6A). Moreover, over-
expression of irf4a repressed the expression of pu.1 in zebrafish
embryos (Figure S6B). These data suggest that Irf4a represses
myeloid fate adoption via negative regulation of Pu.1.
Next, to determine whether Irf4a can regulate pu.1 expression
directly, we performed ChIP using the anti-Myc antibody to
detect Myc-tagged Irf4a. We observed an obvious enrichment
of Irf4a-Myc on the pu.1 promoter containing a conserved Irf4
binding site (Figures 6D–6F), indicating that the transcription of628 Developmental Cell 34, 621–631, September 28, 2015 ª2015 Elspu.1 is directly regulated by Irf4a. To find out how pu.1 transcrip-
tion was upregulated in the absence of Irf4a, we analyzed the
histone acetylation status of the pu.1 promoter region that con-
tains Irf4 binding site and found that the levels of H3K27Ac and
H3K9Ac (both active chromatin marks) were significantly in-
creased (Figure 6G). A previous study reported that Irf4 may re-
cruit Hdac1 to repress the expression of runx3 during thymocyte
differentiation (Cao et al., 2010). This prompted us to examine
whether Hdac1 is also involved in the repression of pu.1 by
Irf4a. Our ChIP results showed that the enrichment of Hdac1 in
the pu.1 promoter was attenuated significantly in irf4a mor-
phants (Figure 6H), suggesting that Irf4a represses pu.1 expres-
sion by recruiting the co-repressor Hdac1. The negative regula-
tion of pu.1 by Irf4a and Hdac1 was confirmed by the reporter
assay (Figure S6C).
In summary, these results demonstrate that Irf4a functions as
a critical determinant for T cell progenitor versusmyeloid cell fate
by repressing pu.1 expression.
DISCUSSION
Earlier hematopoiesis models proposed that downstream of the
HSCs or multipotent progenitors (MPPs), common myeloid pro-
genitors (CMPs) generate GMPs (granulocyte andmonocyte pro-
genitors) andMEPs (megakaryocyte and erythrocyte progenitors)
(Akashi et al., 2000), whereas CLPs differentiate into T cells, B
cells, and natural killer cells. More recently, an alternative model
has been put forward. A Flt3+ population named LMPP has
been identified with both lymphoid and myeloid potentials butevier Inc.
no MEP potential, which is different from CLP or CMP (Adolfsson
et al., 2005). In our study, an increased number of myeloid cells
were observed along with an unaltered erythrocyte population
in the absence of Irf4a in zebrafish. A critical question raised
from this phenotype is where and how these increased myeloid
cells were derived, i.e., LMPPs or lymphoid-restricted progeni-
tors. Irf4a-expressing cells are distinct frommyeloid cells (neutro-
phil and macrophage) based on irf4a expression, and single-cell
tracing experiments showed that they are not differentiated into
lyz-DsRed myeloid cells, indicating that these cells may be
lymphoid-primed progenitors at embryonic stages. However, it
is still uncertain whether Irf4a-expressing cells are completely
devoid of myeloid potential because the lineage assay system
is not available yet in the zebrafish system. Even so, we can con-
clude that myeloid potential is boosted upon blocking lymphoid
potential in the case of Irf4a deficiency during embryogenesis.
Although all blood lineages in the adult are derived fromHSCs,
the T lymphoid lineage—unlike other blood cells, which are
mainly generated in the bone marrow—is specified and com-
mitted in the thymus. The progenitors with T cell potential must
be imported into the thymus for differentiation and maturation.
It has been shown that HSCs and MPPs are unable to settle in
the thymus, while LMPPs and CLPs likely acquire the ability to
settle in the thymus through the expression of necessary homing
factors, such as CCR9 (Benz and Bleul, 2005; Liu et al., 2006;
Schwarz et al., 2007; Uehara et al., 2002). Although CCR9 plays
an important role in T cell homing to the thymus, the mechanism
underlying the regulation ofCcr9 expression is still unclear. In ze-
brafish, we found that ccr9a and irf4a were co-expressed in
lymphoid progenitor cells in the CHT. ChIP experiments and re-
porter assays confirmed the direct binding and regulation of
the ccr9a promoter by Irf4a. Therefore, the preceding results
indicate that Irf4a promotes the expression of ccr9a for T cell
progenitor homing at embryonic stages. At adult stages, T cell
progenitors homing to the thymus are derived from the bone
marrow, and the expression of CCR9 may be regulated by fac-
tors other than Irf4, such as E2A (Dias et al., 2008). In the adult
Irf4 mutant mouse, T cell deficiency in the thymus has not
been previously observed (Mittru¨cker et al., 1997), suggesting
that embryonic and adult T cell progenitors might employ
different regulatory mechanisms.
After seeding the thymus, T lymphoid-primed progenitors
receive Notch signaling and generate ETPs, which are also not
fully committed to T cell fate. These earliest T cell progenitors
in the thymus from an adult or neonatal mouse still possess
the potential for the myeloid lineage and B cells (Bell and Bhan-
doola, 2008; Luc et al., 2012). At fetal stages, to prevent ETPs
from developing into myeloid cells, repression of the myeloid
regulator C/EBPa by the transcriptional repressor Hes1 is re-
quired (De Obaldia et al., 2013). GATA3 is also essential for early
T cell development by suppressing a latent B cell potential begin-
ning at the ETP stage in the mouse embryo (Garcı´a-Ojeda et al.,
2013). However, at prethymic stages, little is known about the
repression of alternate fates for T cell progenitors. Although
Pu.1 is able to induce myeloid lineage commitment in multipo-
tent hematopoietic progenitors in vitro (Nerlov and Graf, 1998),
it is also important for the specification of myelolymphoid line-
ages from HSCs at these earlier stages in mice (Arinobu et al.,
2007). At the intrathymic stages, a certain level of Pu.1 is neces-Developmensary for the development of ETP cells (Champhekar et al., 2015).
In contrast, forced expression of Pu.1 blocks T cell development
at the pro-T cell stage (Anderson et al., 2002). These studies
indicate that Pu.1 may be repressed gradually following T cell
commitment from HSCs. In the thymus, antagonism between
Notch and Pu.1 maintains the identity of T cell progenitor and
prevents the adoption of myeloid fate (Del Real and Rothenberg,
2013; Franco et al., 2006). However, the underlying molecular
mechanism for the downregulation of Pu.1 at the prethymic
stage is still unclear. In our study, during T cell development
at embryonic stages in zebrafish, we found that in the absence
of Irf4a, the increased pu.1 expression in presumptive T lym-
phoid-primed progenitors forced them to adopt the myeloid
fate instead, which indicates that the downregulation of pu.1
by Irf4a is necessary for T lymphoid-primed progenitor determi-
nation. Our study demonstrates that Irf4a plays an important role
in repressing Pu.1 during T lymphoid-primed progenitor commit-
ment at embryonic stages in zebrafish.
It has been reported that there are definitive hematopoietic
precursors predetermined to migrate to the thymus in zebrafish
(Murayama et al., 2006). However, the determinant factors
involved in the specification or commitment of these progenitors
are yet to be unraveled. Based on our findings that irf4a is ex-
pressed and functions in lymphoid or T cell progenitors in the
CHT region as early as 2 dpf, we propose that Irf4a is one of
the earliest factors in predetermined lymphoid-primed progeni-
tors and is responsible for the early seeding of the thymus, while
preventing them from adopting an alternative cell fate during
development. Importantly, we further showed that IRF4 is ex-
pressed in CCR9+ progenitors of mouse FL at E13.5 destined
to enter the thymus, implying that it may also have a similar func-
tion in the mouse, which needs to be further investigated.
In conclusion, Irf4a is a critical transcriptional factor for T
lymphoid-primed progenitor fate determination. Dual roles of
Irf4a have been discovered: on the one hand, it contributes to
the migration of T lymphoid-primed progenitors to the thymus
via upregulating ccr9a expression; on the other hand, it prevents
T lymphoid-primed progenitors from adopting the myeloid cell
fate through downregulation of pu.1.
EXPERIMENTAL PROCEDURES
Zebrafish Husbandry
Zebrafish strains including wild-type, cloche mutant (Stainier et al., 1995),
cmyb:EGFP (North et al., 2007), gata1:GFP (Long et al., 1997), mpo:EGFP
(Renshaw et al., 2006), lyz:DsRed (Hall et al., 2007), and coro1a:EGFP (Li
et al., 2012a) transgenic lines were raised and maintained in system water at
28.5C. The embryos were obtained by natural spawning. This study was
approved by the Ethical ReviewCommittee of the Institute of Zoology, Chinese
Academy of Sciences, Beijing, China.
In Situ Hybridization, qPCR, Western Blotting, ChIP, and Reporter
Assay
The detailed protocols for these experiments are described in the Supple-
mental Experimental Procedures.
Generation of Zebrafish irf4a Mutant by TALEN
The zebrafish irf4a mutant was generated using the FastTALE TALEN kit from
Sidansai Biotechnology. The sequences for the left and right arms were 50-
GCATCATGTCAGTCAGT-30 and 50-GCTCGATGAGCCACTGTC-30 in the first
exon. Capped mRNA for the two arms was synthesized using the mMessagetal Cell 34, 621–631, September 28, 2015 ª2015 Elsevier Inc. 629
mMachine T7 kit (Ambion) and purified with a RNA purification kit (Tiangen).
Two mRNA (140 ng/ml per mRNA) were co-injected into one-cell-stage wild-
type embryos. Injected embryos were incubated at 28.5C and collected for
making genomic DNA for genotyping at 24 hpf. The genomic region flanking
the target site was PCR amplified and sequenced. The PCR product with mu-
tation was cloned into pGEM T vector for confirmation by Sanger sequencing
(BGI, Beijing).
Generation of irf4a Knockin Line with GFP Expression
For the GFP knockin line, the donor vector with the GFP sequence, SV40 late
polyA, and 657-bp homozygous arms flanking the TALEN target site of irf4a
was constructed and co-injected with TALEN mRNA to one-cell-stage em-
bryos spawned by lyz:DsRed transgenic fish according to the method previ-
ously described (Zu et al., 2013). The founder embryos were raised, and
next-generation (F1) progenies with GFP expression were identified by geno-
typing for homologous recombination analysis.
MO, mRNA Synthesis, Microinjection, and Cell Sorting
The detailed protocols for these assays are described in the Supplemental
Experimental Procedures.
TEM and Immunohistochemistry
TEM was performed as previously described (Ma et al., 2012). The method for
immunohistochemistry is described in the Supplemental Experimental
Procedures.
TUNEL Assay, BrdU Labeling, and Confocal Microscopy
All these experiments were conducted as described previously (Wang et al.,
2013).
Generation of Construct for Irf4a Overexpression
The plasmid of HSP-irf4a CDS was constructed with a multisite gateway sys-
tem (Invitrogen) to drive the expression of Irf4a CDS with a heat-shock pro-
moter. The embryos were injected at the one-cell stage and heat-shocked at
42C for 1 hr once a day, starting from 36 to 72 hpf. The embryos with GFP
or without GFP fluorescence were selected and fixed for WISH separately.
Generation of irf4a:GFP Transgenic Line
A 1.9-kb DNA fragment in the irf4a promoter region upstream of its start codon
was amplified and cloned into the pGL3-GFP vector. The acquired construct
was injected into zebrafish embryos at the one-cell stage. The injected
embryos (F0) with mosaic GFP expression were raised to adulthood and
incrossed to obtain the next generation (F1). F1 embryos with stable GFP
expression were selected and raised to adulthood.
Statistical Analysis
Values are presented as mean ± SD. Student’s t test was used to compare
means of different groups, and p values < 0.05 were considered to be signifi-
cant (*p < 0.05, **p < 0.01, and ***p < 0.001).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, two tables, and twomovies and can be found with this article online
at http://dx.doi.org/10.1016/j.devcel.2015.07.011.
AUTHOR CONTRIBUTIONS
S.W. performed most of the experiments, D.M. generated the irf4a/ zebra-
fishmutant and knockin lines using TALENs, Q.H. performed themouse exper-
iments, Y.X. performed the reporter assay, and S.W. and F.L. conceived the
project, analyzed the data, andwrote the paper. All authors read and approved
the final manuscript.
ACKNOWLEDGMENTS
We thank Xuetao Cao, Sten Eirik Jacobsen, Roger Patient, and Philippe
Herbomel for helpful discussions and critical reading of the paper. We thank630 Developmental Cell 34, 621–631, September 28, 2015 ª2015 ElsAnmingMeng, ZilongWen, Jing-Wei Xiong, and Li Li for providing the reagents
used in this work. This work was supported by grants from the National
Basic Research Program of China (2010CB945300, 2011CB943900), the
National Natural Science Foundation of China (31271570, 31425016), and
the Strategic Priority Research Program of the Chinese Academy of Sciences
(XDA01010110).
Received: February 13, 2015
Revised: May 21, 2015
Accepted: July 16, 2015
Published: August 20, 2015
REFERENCES
Adolfsson, J.,Ma˚nsson,R.,Buza-Vidas,N.,Hultquist,A., Liuba,K., Jensen,C.T.,
Bryder, D., Yang, L., Borge, O.J., Thoren, L.A., et al. (2005). Identification of Flt3+
lympho-myeloid stem cells lacking erythro-megakaryocytic potential a revised
road map for adult blood lineage commitment. Cell 121, 295–306.
Akashi, K., Traver, D., Miyamoto, T., and Weissman, I.L. (2000). A clonogenic
commonmyeloid progenitor that gives rise to all myeloid lineages. Nature 404,
193–197.
Anderson, M.K., Weiss, A.H., Hernandez-Hoyos, G., Dionne, C.J., and
Rothenberg, E.V. (2002). Constitutive expression of PU.1 in fetal hematopoiet-
ic progenitors blocks T cell development at the pro-T cell stage. Immunity 16,
285–296.
Arinobu, Y., Mizuno, S., Chong, Y., Shigematsu, H., Iino, T., Iwasaki, H., Graf,
T., Mayfield, R., Chan, S., Kastner, P., and Akashi, K. (2007). Reciprocal acti-
vation of GATA-1 and PU.1 marks initial specification of hematopoietic stem
cells into myeloerythroid and myelolymphoid lineages. Cell Stem Cell 1,
416–427.
Bajoghli, B., Aghaallaei, N., Hess, I., Rode, I., Netuschil, N., Tay, B.H.,
Venkatesh, B., Yu, J.K., Kaltenbach, S.L., Holland, N.D., et al. (2009).
Evolution of genetic networks underlying the emergence of thymopoiesis in
vertebrates. Cell 138, 186–197.
Bell, J.J., and Bhandoola, A. (2008). The earliest thymic progenitors for T cells
possess myeloid lineage potential. Nature 452, 764–767.
Benz, C., and Bleul, C.C. (2005). Amultipotent precursor in the thymusmaps to
the branching point of the T versus B lineage decision. J. Exp. Med. 202,
21–31.
Bleul, C.C., and Boehm, T. (2000). Chemokines define distinct microenviron-
ments in the developing thymus. Eur. J. Immunol. 30, 3371–3379.
Bukrinsky, A., Griffin, K.J., Zhao, Y., Lin, S., and Banerjee, U. (2009). Essential
role of spi-1-like (spi-1l) in zebrafish myeloid cell differentiation. Blood 113,
2038–2046.
Caldero´n, L., and Boehm, T. (2011). Three chemokine receptors cooperatively
regulate homing of hematopoietic progenitors to the embryonic mouse
thymus. Proc. Natl. Acad. Sci. USA 108, 7517–7522.
Cao, Y., Li, H., Sun, Y., Chen, X., Liu, H., Gao, X., and Liu, X. (2010). Interferon
regulatory factor 4 regulates thymocyte differentiation by repressing Runx3
expression. Eur. J. Immunol. 40, 3198–3209.
Champhekar, A., Damle, S.S., Freedman, G., Carotta, S., Nutt, S.L., and
Rothenberg, E.V. (2015). Regulation of early T-lineage gene expression and
developmental progression by the progenitor cell transcription factor PU.1.
Genes Dev. 29, 832–848.
Cretney, E., Xin, A., Shi, W., Minnich, M., Masson, F., Miasari, M., Belz, G.T.,
Smyth, G.K., Busslinger, M., Nutt, S.L., and Kallies, A. (2011). The transcription
factors Blimp-1 and IRF4 jointly control the differentiation and function of
effector regulatory T cells. Nat. Immunol. 12, 304–311.
De Obaldia, M.E., Bell, J.J., Wang, X., Harly, C., Yashiro-Ohtani, Y., DeLong,
J.H., Zlotoff, D.A., Sultana, D.A., Pear, W.S., and Bhandoola, A. (2013). T cell
development requires constraint of the myeloid regulator C/EBP-a by the
Notch target and transcriptional repressorHes1. Nat. Immunol.14, 1277–1284.
Del Real, M.M., and Rothenberg, E.V. (2013). Architecture of a lymphomyeloid
developmental switch controlled by PU.1, Notch and Gata3. Development
140, 1207–1219.evier Inc.
Dias, S., Ma˚nsson, R., Gurbuxani, S., Sigvardsson, M., and Kee, B.L. (2008).
E2A proteins promote development of lymphoid-primed multipotent progeni-
tors. Immunity 29, 217–227.
Franco, C.B., Scripture-Adams, D.D., Proekt, I., Taghon, T., Weiss, A.H., Yui,
M.A., Adams, S.L., Diamond, R.A., and Rothenberg, E.V. (2006). Notch/Delta
signaling constrains reengineering of pro-T cells by PU.1. Proc. Natl. Acad.
Sci. USA 103, 11993–11998.
Gao, Y., Nish, S.A., Jiang, R., Hou, L., Licona-Limo´n, P., Weinstein, J.S., Zhao,
H., and Medzhitov, R. (2013). Control of T helper 2 responses by transcription
factor IRF4-dependent dendritic cells. Immunity 39, 722–732.
Garcı´a-Ojeda, M.E., Klein Wolterink, R.G., Lemaıˆtre, F., Richard-Le Goff, O.,
Hasan, M., Hendriks, R.W., Cumano, A., and Di Santo, J.P. (2013). GATA-3
promotes T-cell specification by repressing B-cell potential in pro-T cells in
mice. Blood 121, 1749–1759.
Gering, M., and Patient, R. (2005). Hedgehog signaling is required for adult
blood stem cell formation in zebrafish embryos. Dev. Cell 8, 389–400.
Hall, C., Flores, M.V., Storm, T., Crosier, K., and Crosier, P. (2007). The zebra-
fish lysozyme C promoter drives myeloid-specific expression in transgenic
fish. BMC Dev. Biol. 7, 42.
Hess, I., and Boehm, T. (2012). Intravital imaging of thymopoiesis reveals dy-
namic lympho-epithelial interactions. Immunity 36, 298–309.
Kissa, K., and Herbomel, P. (2010). Blood stem cells emerge from aortic endo-
thelium by a novel type of cell transition. Nature 464, 112–115.
Klein, U., Casola, S., Cattoretti, G., Shen, Q., Lia, M., Mo, T., Ludwig, T.,
Rajewsky, K., and Dalla-Favera, R. (2006). Transcription factor IRF4 controls
plasma cell differentiation and class-switch recombination. Nat. Immunol. 7,
773–782.
Kondo, M., Weissman, I.L., and Akashi, K. (1997). Identification of clonogenic
common lymphoid progenitors in mouse bone marrow. Cell 91, 661–672.
Langenau, D.M., and Zon, L.I. (2005). The zebrafish: a newmodel of T-cell and
thymic development. Nat. Rev. Immunol. 5, 307–317.
Li, L., Leid, M., and Rothenberg, E.V. (2010). An early T cell lineage commit-
ment checkpoint dependent on the transcription factor Bcl11b. Science 329,
89–93.
Li, L., Yan, B., Shi, Y.Q., Zhang, W.Q., and Wen, Z.L. (2012a). Live imaging re-
veals differing roles of macrophages and neutrophils during zebrafish tail fin
regeneration. J. Biol. Chem. 287, 25353–25360.
Li, P., Spolski, R., Liao, W., Wang, L., Murphy, T.L., Murphy, K.M., and
Leonard, W.J. (2012b). BATF-JUN is critical for IRF4-mediated transcription
in T cells. Nature 490, 543–546.
Liu, C., Saito, F., Liu, Z., Lei, Y., Uehara, S., Love, P., Lipp, M., Kondo, S.,
Manley, N., and Takahama, Y. (2006). Coordination between CCR7- and
CCR9-mediated chemokine signals in prevascular fetal thymus colonization.
Blood 108, 2531–2539.
Long, Q., Meng, A., Wang, H., Jessen, J.R., Farrell, M.J., and Lin, S. (1997).
GATA-1 expression pattern can be recapitulated in living transgenic zebrafish
using GFP reporter gene. Development 124, 4105–4111.
Luc, S., Luis, T.C., Boukarabila, H., Macaulay, I.C., Buza-Vidas, N., Bouriez-
Jones, T., Lutteropp, M., Woll, P.S., Loughran, S.J., Mead, A.J., et al. (2012).
The earliest thymic T cell progenitors sustain B cell andmyeloid lineage poten-
tial. Nat. Immunol. 13, 412–419.
Ma, D., Wang, L., Wang, S., Gao, Y., Wei, Y., and Liu, F. (2012). Foxn1 main-
tains thymic epithelial cells to support T-cell development via mcm2 in zebra-
fish. Proc. Natl. Acad. Sci. USA 109, 21040–21045.
Mittru¨cker, H.W., Matsuyama, T., Grossman, A., Ku¨ndig, T.M., Potter, J.,
Shahinian, A., Wakeham, A., Patterson, B., Ohashi, P.S., and Mak, T.W.
(1997). Requirement for the transcription factor LSIRF/IRF4 for mature B and
T lymphocyte function. Science 275, 540–543.
Murayama, E., Kissa, K., Zapata, A., Mordelet, E., Briolat, V., Lin, H.F., Handin,
R.I., and Herbomel, P. (2006). Tracing hematopoietic precursor migration to
successive hematopoietic organs during zebrafish development. Immunity
25, 963–975.
Nerlov, C., and Graf, T. (1998). PU.1 induces myeloid lineage commitment in
multipotent hematopoietic progenitors. Genes Dev. 12, 2403–2412.DevelopmenNorth, T.E., Goessling, W., Walkley, C.R., Lengerke, C., Kopani, K.R., Lord,
A.M., Weber, G.J., Bowman, T.V., Jang, I.H., Grosser, T., et al. (2007).
Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis.
Nature 447, 1007–1011.
Ochiai, K., Maienschein-Cline, M., Simonetti, G., Chen, J., Rosenthal, R.,
Brink, R., Chong, A.S., Klein, U., Dinner, A.R., Singh, H., and Sciammas, R.
(2013). Transcriptional regulation of germinal center B and plasma cell fates
by dynamical control of IRF4. Immunity 38, 918–929.
Raczkowski, F., Ritter, J., Heesch, K., Schumacher, V., Guralnik, A., Ho¨cker,
L., Raifer, H., Klein, M., Bopp, T., Harb, H., et al. (2013). The transcription factor
Interferon Regulatory Factor 4 is required for the generation of protective
effector CD8+ T cells. Proc. Natl. Acad. Sci. USA 110, 15019–15024.
Renshaw, S.A., Loynes, C.A., Trushell, D.M., Elworthy, S., Ingham, P.W., and
Whyte, M.K. (2006). A transgenic zebrafishmodel of neutrophilic inflammation.
Blood 108, 3976–3978.
Rodewald, H.R. (1995). Pathways from hematopoietic stem cells to thymo-
cytes. Curr. Opin. Immunol. 7, 176–187.
Rodewald, H.R., Kretzschmar, K., Takeda, S., Hohl, C., and Dessing, M.
(1994). Identification of pro-thymocytes in murine fetal blood: T lineage
commitment can precede thymus colonization. EMBO J. 13, 4229–4240.
Sambandam, A., Maillard, I., Zediak, V.P., Xu, L., Gerstein, R.M., Aster, J.C.,
Pear, W.S., and Bhandoola, A. (2005). Notch signaling controls the generation
and differentiation of early T lineage progenitors. Nat. Immunol. 6, 663–670.
Schwarz, B.A., Sambandam, A., Maillard, I., Harman, B.C., Love, P.E., and
Bhandoola, A. (2007). Selective thymus settling regulated by cytokine and che-
mokine receptors. J. Immunol. 178, 2008–2017.
Shah, D.K., and Zu´n˜iga-Pflu¨cker, J.C. (2014). An overview of the intrathymic
intricacies of T cell development. J. Immunol. 192, 4017–4023.
Stainier, D.Y.,Weinstein, B.M., Detrich, H.W., 3rd, Zon, L.I., and Fishman,M.C.
(1995). Cloche, an early acting zebrafish gene, is required by both the endothe-
lial and hematopoietic lineages. Development 121, 3141–3150.
Staudt, V., Bothur, E., Klein, M., Lingnau, K., Reuter, S., Grebe, N., Gerlitzki, B.,
Hoffmann, M., Ulges, A., Taube, C., et al. (2010). Interferon-regulatory factor 4
is essential for the developmental program of T helper 9 cells. Immunity 33,
192–202.
Tamura, T., Yanai, H., Savitsky, D., and Taniguchi, T. (2008). The IRF family
transcription factors in immunity and oncogenesis. Annu. Rev. Immunol. 26,
535–584.
Tan, J.B., Visan, I., Yuan, J.S., and Guidos, C.J. (2005). Requirement for
Notch1 signals at sequential early stages of intrathymic T cell development.
Nat. Immunol. 6, 671–679.
Trede, N.S., Langenau, D.M., Traver, D., Look, A.T., and Zon, L.I. (2004). The
use of zebrafish to understand immunity. Immunity 20, 367–379.
Uehara, S., Grinberg, A., Farber, J.M., and Love, P.E. (2002). A role for CCR9 in
T lymphocyte development and migration. J. Immunol. 168, 2811–2819.
Vasanthakumar, A., Moro, K., Xin, A., Liao, Y., Gloury, R., Kawamoto, S.,
Fagarasan, S., Mielke, L.A., Afshar-Sterle, S., Masters, S.L., et al. (2015).
The transcriptional regulators IRF4, BATF and IL-33 orchestrate development
and maintenance of adipose tissue-resident regulatory T cells. Nat. Immunol.
16, 276–285.
Wang, L., Liu, T., Xu, L., Gao, Y., Wei, Y., Duan, C., Chen, G.Q., Lin, S., Patient,
R., Zhang, B., et al. (2013). Fev regulates hematopoietic stem cell development
via ERK signaling. Blood 122, 367–375.
Weber, B.N., Chi, A.W., Chavez, A., Yashiro-Ohtani, Y., Yang, Q., Shestova,
O., and Bhandoola, A. (2011). A critical role for TCF-1 in T-lineage specification
and differentiation. Nature 476, 63–68.
Yang, Q., Jeremiah Bell, J., and Bhandoola, A. (2010). T-cell lineage determi-
nation. Immunol. Rev. 238, 12–22.
Yao, S., Buzo, B.F., Pham, D., Jiang, L., Taparowsky, E.J., Kaplan, M.H., and
Sun, J. (2013). Interferon regulatory factor 4 sustains CD8(+) T cell expansion
and effector differentiation. Immunity 39, 833–845.
Zu, Y., Tong, X.,Wang, Z., Liu, D., Pan, R., Li, Z., Hu, Y., Luo, Z., Huang, P., Wu,
Q., et al. (2013). TALEN-mediated precise genome modification by homolo-
gous recombination in zebrafish. Nat. Methods 10, 329–331.tal Cell 34, 621–631, September 28, 2015 ª2015 Elsevier Inc. 631
